Compare ALDX & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALDX | URG |
|---|---|---|
| Founded | 2004 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.0M | 477.8M |
| IPO Year | 2014 | N/A |
| Metric | ALDX | URG |
|---|---|---|
| Price | $5.30 | $1.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $9.50 | $2.52 |
| AVG Volume (30 Days) | 1.7M | ★ 13.2M |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $39,411,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $36.25 | $183.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 138.94 |
| 52 Week Low | $1.14 | $0.55 |
| 52 Week High | $7.20 | $2.35 |
| Indicator | ALDX | URG |
|---|---|---|
| Relative Strength Index (RSI) | 53.73 | 52.81 |
| Support Level | $4.90 | $1.28 |
| Resistance Level | $5.75 | $1.48 |
| Average True Range (ATR) | 0.48 | 0.08 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 74.24 | 67.65 |
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.